The effect of chronic clozapine on basal dopamine release and apomorphine-induced DA release in the striatum and nucleus accumbens as measured by in vivo brain microdialysis

Neuroscience Letters

Volumn 140, Issue 1, 1992, Pages 47-50

  Chai, Baoling ^a   Meltzer, Herbert Y ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apomorphine; Clozapine; Dopamine; Microdialysis; Nucleus accumbens; Striatum

Indexed keywords

APOMORPHINE; CLOZAPINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MICRODIALYSIS; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMAL; APOMORPHINE; CLOZAPINE; CORPUS STRIATUM; DIALYSIS; DOPAMINE; HOMOVANILLIC ACID; HYDROXYINDOLEACETIC ACID; KINETICS; MALE; NUCLEUS ACCUMBENS; RATS; RATS, WISTAR; REFERENCE VALUES; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; TIME FACTORS;

EID: 0026695723     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3940(92)90678-Z     Document Type: Article

References (19)

1. Chronic treatment with classical and atypical antipsychotic drugs differentially decreases dopamine release in striatum and nucleus accumbens in vivo
2. Acute and chronic haloperidol treatment: comparison of effect on nigral dopaminergic cell activity
3. Chronic treatment with clozapine selectively decreases basal dopamine release in nucleus accumbens but not in caudate-putamen as measured by in vivo brain microdialysis: further evidence for depolarization block
4. Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons
5. Possible mechanism by which repeated clozapine administration on activity of two subpopulations of midbrain dopamine neurons
6. Dopaminergic-cholinergic interactions in the striatum: the critical significance of calcium concentrations in brain microdialysis
7. Induction of depolarization block in midbrain dopamine neurons by repeated administration of haloperidol: analysis using in vivo intracellular recording
8. Apomorphine does not reverse reduced basal dopamine release in rat striatum and nucleus accumbens after chronic haloperidol treatment
9. The effect of chronic clozapine and haloperidol on basal dopamine release and metabolism in rat striatum and nucleus accumbens studied by in vivo microdialysis
10. Differential effects of repeated treatment with haloperidol and clozapine on dopamine release and metabolism in the striatum and the nucleus accumbens
11. Effects of acute and chronic clozapine on dopamine release and metabolism in the striatum and nucleus accumbens of conscious rats
12. Chronic haloperidol decreases dopamine release in striatum and nucleus accumbens in vivo: depolarization block as a possible mechanism of action
13. Selective inhibition of mesolimbic dopamine release following chronic administration of clozapine: involvement of 1-noradrenergic receptors demonstrated by in vivo voltammetry
14. Ionic composition of microdialysis perfusing solution alters the pharmacological responsiveness and basal outflow of striatal dopamine
15. Clozapine — A new antipsychotic agent
16. Differential effects after repeated treatment with haloperidol, clozapine, thioridazine and tefludazine on SNC and VTA dopamine neurons in rats
17. The significance of extracellular calcium for the release of dopamine, acetylcholine, and amino acids in conscious rats evaluated by brain microdialysis
18. Comparison of the effects of chronic haloperidol treatment on A9 and A10 dopamine neurons in the rat
19. Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons